ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

OGN Organon and Co

20.27
0.66 (3.37%)
최종 업데이트: 01:57:57
15분 지연
기업명 주식 심볼 시장 주식 타입
Organon and Co OGN NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.66 3.37% 20.27 01:57:57
개장가 저가 고가 종가 전일 종가
19.75 19.59 20.39 19.61
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202420:30BWOrganon Reports Results for the First Quarter Ended March..
09/04/202421:13BWProlia ® とXgeva ®..
09/04/202403:31BWL'essai clinique comparatif de phase 3 du candidat..
08/04/202419:15BWOrganon To Report First Quarter 2024 Results and Host..
08/04/202419:00BWPhase 3 Comparative Clinical Study of Prolia® and Xgeva®..
08/03/202423:01PRNCAOn International Women's Day, Organon Canada is encouraging..
02/03/202406:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202406:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202406:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202406:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/02/202422:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
24/02/202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/02/202422:00BWOrganon Announces HADLIMA™ (adalimumab-bwwd) Has Been..
15/02/202421:48EDGAR2Form 8-K - Current report
15/02/202421:30BWOrganon Reports Results for the Fourth Quarter and Full Year..
14/02/202406:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202421:30BWOrganon To Report Fourth Quarter and Full Year Results and..
10/01/202421:33BWOrganon’s XACIATO™ (clindamycin phosphate) Vaginal Gel 2%..
08/01/202421:30BWOrganon affirms 2023 revenue and Adjusted EBITDA guidance..
21/12/202321:30BWOrganon To Present at the 42nd Annual J.P. Morgan Healthcare..
19/12/202322:30BWOrganon et Lilly concluent un accord de commercialisation en..
19/12/202318:11BWOrganon と Lilly、ヨーロッパで 2 種類の片頭痛薬商業化契約を締結
19/12/202311:26BWOrganon und Lilly schließen Vermarktungsvereinbarung für..
18/12/202321:30BWOrganon & Lilly Enter Commercialization Agreement in Europe..
06/12/202306:31EDGAR2Form 8-K - Current report
21/11/202321:30BWOrganon To Present at the Piper Sandler 35th Annual..
08/11/202306:15GLOBESamsung Bioepis & Organon Announce FDA Acceptance of..
03/11/202320:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202320:38EDGAR2Form 8-K - Current report
02/11/202320:30BWOrganon Reports Results for the Third Quarter Ended..
01/11/202320:30BWOrganon and Sempre Health Announce Collaboration on New..
26/10/202320:00PRNCAOrganon Canada annonce la disponibilité d'une préparation..
19/10/202320:30BWOrganon To Report Third Quarter Results and Host Conference..
14/10/202307:02PRNUSLululemon Athletica & Hubbell Set to Join S&P 500; Others to..
28/09/202304:13BWOrganon figure sur la liste « Change the World » de Fortune..
28/09/202302:43BWオルガノン、フォーチュン誌の2023年チェンジ・ザ・ワールドリストで避妊の選択肢へのアクセスを拡大するリーダーシップで表彰される
28/09/202302:33BWOrganon auf der Fortune „Change the World“-Liste 2023 für..
27/09/202320:30BWOrganon Recognized on Fortune’s 2023 Change the World List..
26/09/202320:01PRNCAOn World Contraception Day, Organon Canada Declares Support..
15/09/202306:12BWFirst Real-World Observational Study of the JADA® System, a..
06/09/202308:38BWオルガノン、2人のリーダー任命で研究開発の専門知識を強化
06/09/202305:27BWOrganon renforce ses capacités de recherche et de..
06/09/202302:52BWOrganon stärkt Forschungs- und Entwicklungskompetenz mit..
05/09/202323:00BWOrganon Bolsters Research & Development Expertise with Two..
09/08/202321:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202320:58EDGAR2Form 8-K - Current report
08/08/202320:30BWOrganon Reports Results for the Second Quarter Ended June..
01/08/202320:00GLOBESamsung Bioepis & Organon Announce Topline Results from..
17/07/202320:30BWOrganon To Report Second Quarter Results and Host Conference..
08/07/202305:05EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock